Medicine
The first CRISPR gene-editing medicine is approved for sickle cell disease
Casgevy edits a patient's own blood stem cells so their body makes healthy foetal haemoglobin again.
New treatments, gene editing and AI in healthcare.
1 storyCasgevy edits a patient's own blood stem cells so their body makes healthy foetal haemoglobin again.